| Presented by: | The Cleveland Clinic Foundation Center for Continuing Education |
| Lecturer | Jeffrey D. Greenberg, MD, MPH |
| Approximate duration: | 30 mins. |
| Summary points: | This audiovisual presentation discusses the background risk factors for infection in rheumatoid arthritis (RA) and use of biologic therapies, as well as the latest information regarding rare infections that may be associated with the use of biologic therapies in these patients. |
| Accreditation: | The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s).
Expiration Date: February 5, 2010. |
| Other: | |
E-Mail this webcast/CME to a colleague
Relative Risks of Serious Bacterial and Opportunistic Infections Among Biologics: Results of Randomized Trials and Observational Studies
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
